At the 42nd annual event for investors, pharma executives and biotech innovators, the spotlight was on AI, the new GLP-1 class of weight loss drugs, non-profit hospitals and treatment for autoimmune disease.

The use of AI in employment is truly a new frontier. AI reflects the world from which it learns and those who create it. Employers cannot rely on AI tools alone for employee recruitment and management. Proactively mitigating algorithmic bias is not only warranted but, in some forward-thinking jurisdictions, mandatory.

Manufacturing problems, including failure to properly maintain facilities and equipment, were discovered at Lilly's New Jersey plant during an FDA inspection, as the drugmaker's weight-loss medication Zepbound is in high demand.

Racial and ethnic earning disparities associated with health insurance premium growth have increased over time.